Heptares Therapeutics Investors
Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).
Number Of Exists:
N/A
Technology:
Advanced BioTech R&D
Industry:
PharmTech
Founded Date:
2007
Investor Type:
Healthcare Company
Employee Number:
11-50
Headquarters:
Welwyn Garden City, Hertford, United Kingdom